Showing results (1631-1640 of 1,957) with videos related to

Sort By:
Pageof 196
American Heart Journal|July 29, 2014
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registryBenjamin A Steinberg, Rosalia G Blanco, Donna Ollis, et al.
Leukemia & Lymphoma|September 25, 2014
Survival in patients with limited-stage peripheral T-cell lymphomasRobert Briski, Andrew L Feldman, Nathaniel G Bailey, et al.
Blood Cancer Journal|July 3, 2025
Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detectionSuheil Albert Atallah-Yunes, Matthew J Rees, Raphael Mwangi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2021
Vaccination History and Risk of Lymphoma and Its Major SubtypesGeffen Kleinstern, Melissa C Larson, Stephen M Ansell, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 21, 2010
Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsiesDavid A Wada, Mark E Law, Eric D Hsi, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2019
Potent bicyclic inhibitors of malarial cGMP-dependent protein kinase: approaches to combining improvements in cell potency, selectivity and structural noveltyJonathan M Large, Kristian Birchall, Nathalie S Bouloc, et al.
Leukemia & Lymphoma|August 20, 2005
The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphomaYinlee Yoong, Luis F Porrata, David J Inwards, et al.
Blood|May 19, 2019
Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphomaXiaosheng Wu, Mary Stenson, Jithma Abeykoon, et al.
British Journal of Haematology|August 27, 2024
CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphomaEmil Arjun Kumar, Koorosh Korfi, Findlay Bewicke-Copley, et al.
Blood Cancer Journal|August 17, 2023
Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicityWilliam G Breen, Jason R Young, Matthew A Hathcock, et al.
Pageof 196